Chelsea, AL, United States of America

Stephen W Burgess

USPTO Granted Patents = 16 


 

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 66(Granted Patents)


Location History:

  • Montevallo, AL (US) (1999)
  • Columbiana, AL (US) (2008 - 2012)
  • Chelsea, AL (US) (2010 - 2022)
  • Alabaster, AL (US) (2022)

Company Filing History:


Years Active: 1999-2022

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stephen W. Burgess

Introduction

Stephen W. Burgess, an esteemed inventor based in Chelsea, Alabama, holds an impressive portfolio of 16 patents. His work primarily focuses on advancing medical and drug delivery technologies, revealing a significant dedication to innovation in the field of pharmaceuticals.

Latest Patents

Among his latest innovations, Burgess has developed an oral composition for the delivery of drugs and other substances. This patent outlines a composition that facilitates the solubilization of an agent or enables oral administration, comprising a lysophosphatidyl compound along with either a monoglyceride or a free fatty acid. Additionally, he has contributed to therapies aimed at treating and preventing chronic rhinosinusitis, presenting methods for disrupting bacterial biofilms through antibiotic compounds combined with phospholipid compounds. These inventions showcase the potential for impactful applications in healthcare.

Career Highlights

Stephen W. Burgess has made significant strides in his career, working with notable organizations such as Avanti Polar Lipids, Inc. and Ac Immune SA. His experiences in these companies have honed his expertise in biochemistry and drug formulation, paving the way for his impactful inventions.

Collaborations

Throughout his career, Burgess has collaborated with talented individuals in the field, including colleagues such as Walter Allen Shaw and Shengrong Li. These partnerships have likely contributed to the depth and success of his innovations, fostering a collaborative environment conducive to creativity and progress.

Conclusion

Stephen W. Burgess exemplifies the spirit of innovation within the pharmaceutical industry. His substantial patent portfolio and collaborations underscore his dedication to developing advanced solutions for medical challenges. As he continues to push the boundaries of drug delivery and treatment methodologies, his contributions are poised to make a lasting impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…